Schott in €75 million Indian amber glass investment

Published 17th March, 2023 by Greg Morris

Schott celebrated the start of an amber glass manufacturing unit for pharmaceutical glass production in Gujarat, India this week.

Speciality glass manufacturer Schott has invested €75 million to expand its pharma glass production in India.

The Gujarat-based facility is the company’s manufacturing hub for borosilicate glass tubing, a material that is converted to pharmaceutical containers, such as vials, ampoules, or syringes, to store life-saving drugs.

The expansion contributes to the Indian government’s vision of strengthening India as a global pharmaceutical hub, while also supporting Germany’s commitment to invest in India.

Local government officials, business unit executives, and pharma industry representatives celebrated the start of a new production of Fiolax amber pharmaceutical glass tubing at a celebration ceremony this week.

With this move, manufacturers of drug containment solutions in the region can receive Schott's complete portfolio of pharmaceutical glass tubing produced in India.

Amber glass is used to store light-sensitive medications such as antibiotics or chemotherapeutic agents.

The local production will also improve availability, planning reliability, and cost efficiency for pharmaceutical converters.

Greg Morris

Glass International Editor

Greg Morris has been editor of Glass International and organiser of the Glassman conferences since 2012, specialising in glass packaging. Prior to this he spent five years working in newspaper journalism.